Celgene will pay $75m upfront to get an option on three cancer programmes developed by Immatics...
Up To Date
Latest News
Danish microbiology specialist Unibio International plc had completed a US$15m financing round led by West...
US company Freenome will use its multiomics platform to develop response biomarkers to ADC Therapeutics’ Phase...
GlaxoSmithKline plc announced belantamab mafodotin (GSK2857916) met the primary endpoint of overall response...
Researchers from Paul Scherrer Institute in Villingen, Switzerland, and Hoffmann La-Roche AG report in Cell...
An antibody therapy that targets red blood cells (RBCs) unexpectedly showed anti-inflammatory effects and...
Share
